Inan Nagihan, Arslan Arzu, Akansel Gur, Anik Yonca, Balci N Cem, Demirci Ali
Department of Radiology, School of Medicine, University of Kocaeli, 41380 Umuttepe, Kocaeli, Turkey.
Eur J Radiol. 2008 Jan;65(1):154-62. doi: 10.1016/j.ejrad.2007.03.012. Epub 2007 Apr 26.
To evaluate the value of dynamic MR imaging in the differential diagnosis of adrenal adenomas and malignant tumors, especially in cases with atypical adenomas.
Sixty-four masses (48 adenomas, 16 malignant tumors) were included in this prospective study. Signal loss of masses was evaluated using chemical shift MR imaging. Five dynamic series of T1-weighted spoiled gradient echo (FFE) images were obtained, with the acquisition starting simultaneously with i.v. contrast administration (0-100 s) followed by a T1-weighted FFE sequence in the late phase (5th minute). Contrast enhancement patterns in the early (25th second) and late (5th minute) phase images were evaluated. For the quantitative evaluation, signal intensity (SI)-time curves were obtained according to the SIs on the 0th, 25th, 50th 75th and 100th second. Also, the wash-in rate, maximum relative enhancement, time-to-peak, and wash-out of contrast at 100 s of masses in both groups were calculated. The statistical significance was determined by Mann-Whitney U test. To evaluate the diagnostic performance of the quantitative tests, receiver operating characteristic (ROC) analysis was performed.
Chemical shift MR imaging was able to differentiate 44 out of 48 adenomas (91.7%) from non-adenomas. The 4 adenomas (8.3%) which could not be differentiated from non-adenomas by this technique did not exhibit signal loss on out-of-phase images. With a cut-off value of 30, SI indices of adenomas had a sensitivity of 93.8%, specificity of 100% and a positive predictive value of 100%. On visual evaluation of dynamic MR imaging, early phase contrast enhancement patterns were homogeneous in 75% and punctate in 20,83% of the adenomas; while patchy in 56.25% and peripheral in 25% of the malignant tumors. On the late phase images 58.33% of the adenomas showed peripheral ring-shaped enhancement and 10.41% showed heterogeneous enhancement. All of the malignant masses showed heterogeneous enhancement. At the 25th second, the SIs and wash-in rates of the adenomas were significantly higher than those of the malignant masses (p=0.010). Time-to-peak enhancement of the malignant masses was significantly longer than that of the adenomas. With a cut-off value of 52.85 s, the time-to-peak enhancement had 87.5% sensitivity and 80% specificity.
Chemical shift MR has a high sensitivity and specificity in the differential diagnosis of adenomas and malignant adrenal masses. However, taking into consideration only the atypical adenomas, chemical shift MRI is of no diagnostic value. Although the diagnostic value of dynamic MRI is lower than chemical shift MRI, in the atypical cases contrast enhancement patterns and time-to-peak and wash-in rates derived from SI-time curve of dynamic MRI give are contributory to the results of chemical shift MRI.
评估动态磁共振成像(MRI)在肾上腺腺瘤与恶性肿瘤鉴别诊断中的价值,尤其是在非典型腺瘤病例中的价值。
本前瞻性研究纳入了64个肿块(48个腺瘤,16个恶性肿瘤)。采用化学位移MRI评估肿块的信号丢失情况。获取了5个动态系列的T1加权扰相梯度回波(FFE)图像,采集在静脉注射造影剂的同时开始(0 - 100秒),随后在延迟期(第5分钟)进行T1加权FFE序列扫描。评估早期(第25秒)和晚期(第5分钟)图像中的对比增强模式。为进行定量评估,根据第0、25、50、75和100秒的信号强度(SI)获取SI - 时间曲线。此外,计算了两组肿块在100秒时的对比剂流入率、最大相对增强、达峰时间和对比剂廓清情况。采用Mann - Whitney U检验确定统计学意义。为评估定量检测的诊断性能,进行了受试者操作特征(ROC)分析。
化学位移MRI能够将48个腺瘤中的44个(91.7%)与非腺瘤区分开来。通过该技术无法与非腺瘤区分的4个腺瘤(8.3%)在反相位图像上未表现出信号丢失。以30为临界值,腺瘤的SI指数敏感性为93.8%,特异性为100%,阳性预测值为100%。在动态MRI的视觉评估中,75%的腺瘤早期对比增强模式均匀,20.83%为点状;而56.25%的恶性肿瘤为斑片状,25%为周边强化。在晚期图像上,58.33%的腺瘤表现为周边环形强化,10.41%表现为不均匀强化。所有恶性肿块均表现为不均匀强化。在第25秒时,腺瘤的SI和流入率显著高于恶性肿块(p = 0.010)。恶性肿块的达峰时间显著长于腺瘤。以52.85秒为临界值,达峰时间的敏感性为87.5%,特异性为80%。
化学位移MRI在肾上腺腺瘤与恶性肿块的鉴别诊断中具有较高的敏感性和特异性。然而,仅考虑非典型腺瘤时,化学位移MRI无诊断价值。尽管动态MRI的诊断价值低于化学位移MRI,但在非典型病例中,动态MRI的对比增强模式以及从SI - 时间曲线得出的达峰时间和流入率有助于化学位移MRI的诊断结果。